16. Crow-Fukase syndrome Clinical trials / Disease details
Clinical trials : 13 / Drugs : 18 - (DrugBank : 8) / Drug target genes : 5 - Drug target pathways : 81
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02193698 (ClinicalTrials.gov) | July 2014 | 16/7/2014 | Efficacy and Safety of Lenalidomide as a Treatment for Recurrent or Refractory POEMS Syndrome Trial | Single Arm Open-label Trial to Investigate the Efficacy and Safety of Lenlidomide as a Treatment for Recurrent or Refractory Crow-Fukase (POEMS) Syndrome | POEMS Syndrome | Drug: Lenalidomide+Dexamethasone | Chiba University | NULL | Completed | 20 Years | N/A | Both | 5 | Phase 2 | Japan |